EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

RETRACTION: Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy

Editors of Cancer Research and Treatment

Cancer Research and Treatment · 15.07.2026 · 58 (3) · 1024-1024

DOI: 10.4143/crt.2017.085.re ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Research and Treatment, erschienen am 15.07.2026. Verfasst von Editors of Cancer Research and Treatment. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper [1] has been retracted at the request of all authors.In March 2026, an issue regarding image duplication was raised regarding the published paper.Specifically, (1) identical images were duplicated within the paper, and (2) another image was identified as identical to an image in a separate paper published in a different journal [2].The corresponding author (SJK) acknowledged these image duplications and agreed that the integrity and reliability of the reported data could not be fully guaranteed.SJK requested the retraction of the paper, and all co-authors agreed to the retraction.The editors of Cancer Research and Treatment underwent discussion and deliberation on this issue and, in accordance with the guidelines of the International Committee of Medical Journal Editors, decided (1) to retract this article and (2) to notify the relevant

Zitieren

APA

Editors of Cancer Research and Treatment (2026). RETRACTION: Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy. Cancer Research and Treatment, 58(3), 1024-1024. https://doi.org/10.4143/crt.2017.085.re

Vancouver

Editors of Cancer Research and Treatment. RETRACTION: Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy. Cancer Research and Treatment. 2026;58(3):1024-1024. doi:10.4143/crt.2017.085.re

BibTeX
@article{EditorsofCancerResearchandTreatment2026,
  author = {Editors of Cancer Research and Treatment, Editors of Cancer Research and Treatment},
  title = {RETRACTION: Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy},
  journal = {Cancer Research and Treatment},
  year = {2026},
  volume = {58},
  number = {3},
  pages = {1024--1024},
  doi = {10.4143/crt.2017.085.re}
}
Kostenlos starten →